The company says it can make high-activity enzymes on a large commercial scale.
Biocatalysts Ltd. (Bensenville, IL) is building what it says is a unique production plant for specialty intracellular enzymes. The new plant improves efficiency of production for an otherwise costly and troublesome process.
The company says that while today’s enzymes can be easy to produce in large batches, its specialty enzymes undergo a cell breaker process that releases the enzyme from its sludge after fermentation. While producing these enzymes is possible in small-scale operations, large-scale operations have traditionally been viewed as quite challenging, if not impossible. Now, Biocatalysts says its new plant can produce batches of up to hundreds of kilograms of high-activity, freeze-dried enzymes.
“In the past, customers would go to a contract research company for enzyme development and then look for a contract manufacturing company to make the enzyme,” says Stuart West, Biocatalysts managing director. “Having all this under one roof enables us to develop novel enzymes very rapidly and cost-effectively.”
Driving Sustainability in Nutraceuticals: How Ingredient Brands Are Raising the Bar
April 26th 2024Health-minded consumers, especially Generation Z, value nutraceutical companies with sustainability embedded into their corporate philosophy—from product development to packaging. This article discusses how responsible companies are responding to the consumer call for greater sustainability by implementing environmentally friendly manufacturing practices that ultimately lead to waste reduction, improved supplier communications and lower supply chain risk. Those who have taken steps to demonstrate a genuine commitment to sustainability are standing out with improved outcomes for all.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.